Eli Lilly & Co.

NYS : LLY
Pharmaceuticals
Indianapolis IN
Revenue (US$ Millions)$19,616
Revenue Growth (%)-15.13%
Net Income (Millions)$2,391
Common Shares Outstanding (Millions)$1,111
Earnings per Share$2.23
Price To Earnings Ratio32.66
Total Equity (Millions)$15,373
Profit Margin 112.19%
Return on Equity13.56%
Long Term Debt (US$ Millions)$5,368
Debt To Equity Ratio (%)0.35%
Market Capitalization (US$ Millions)$76,622
Total Assets (US$ Millions)$37,178
Return on Assets (%)6.78
Current Assets (US$ Millions)$12,180
Inventories (US$ Millions)$2,740
Current Liabilities (US$ Millions)$11,208
Cost of Goods Sold (US$ Millions)$4,933
Asset Turnover0.53
Inventory Turnover1.74